Terlipressin avoids hemodialysis in the treatment of refractory hyperkalemia associated with renal dysfunction in cirrhosis.
Kalambokis
Georgios
G
Department of Internal Medicine, Medical School of Ioannina, Greece.
Milionis
Haralampos
H
Elisaf
Moses
M
Tsianos
Epameinondas V
EV
D006530:Hepatorenal Syndrome / Q000150:complications*; D006801:Humans; D006947:Hyperkalemia / Q000188:drug therapy* / Q000209:etiology*; D008103:Liver Cirrhosis / Q000150:complications*; D008236:Lypressin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012076:Renal Agents / Q000627:therapeutic use*; D000077585:Terlipressin
D012076:Renal Agents; D008236:Lypressin; D000077585:Terlipressin